Isoliquiritigenin, one of the major constituents of Glycyrrhiza uralensis (licorice), is a natural pigment with a simple chalcone structure 4,2′,4′-trihydroxychalcone. In this study, isoliquiritigenin showed selective H 2 histamine receptor (H 2 R) antagonistic effect and remarkably reduced several H 2 R-mediated physiological responses. Preincubation of U937 and Moreover, isoliquiritigenin reduced gastric acid secretion and protected gastric mucosal lesion formation in pylori ligated rat model. Taken together, the results demonstrate that isoliquiritigenin is an effective H 2 R antagonist and provides the basis for designing novel H 2 R antagonist.
Introduction
Histamine is one of the aminergic neurotransmitters, and plays an important role in the regulation of several pathophysiological processes (Jutel et al., 2005b) . Histamine is found in every human tissue and can play as a local hormone, a mediator in processes related to allergy and inflammation, or a neurotransmitter (Jutel et al., 2005a) . Histamine exerts its effect through H 1 , H 2 , H 3 , and H 4 receptors (Gutzmer et al., 2005) . Specially, the H 2 histamine receptor (H 2 R) is coupled to the Gs-protein / adenylyl cyclase system in a variety of tissues (e.g. brain, stomach, heart, gastric mucosa, lung) and produces intracellular cyclic adenosine monophosphate (cAMP) (Alewijnse et al., 1998) . Gantz et al were the first to clone a cDNA encoding a 359 amino acid H 2 R. Using degenerate primers based on the known sequence similarity of various GPCRs, the H 2 R sequence was obtained from canine gastric parietal cDNA by PCR (Gantz et al., 1991) . Soon thereafter, the intronless genes encoding the rat, human, guinea-pig and mouse H 2 R were cloned by means of homology screening (Gantz et al., 1991) . Many reports demonstrated the cellular function of H 2 R and its importance. In immune system, the responses of T helper cell(Th1 and Th2) are negatively regulated by H 2 R through the activation of different biochemical intracellular signals (Jutel et al., 2001) . The presence of H 2 R in U937 (promyelocytic lymphoma cell line) (Shayo et al., 2004) , HL-60 (promyelocytic leukemia cell line) (Suh et al., 2001) , and MKN-45 (gastric cancer cell line) (Arima et al., 1991) cells has been reported.
Licorice root (G. uralensis) is used as a harmonizing ingredient in many traditional herbal formulations. It is used in more formulations than any other herb in oriental medicine. Though it is considered to be the quintessential "servant" herb, it is often refered to as the King of Herbs.
Although the flavonoid-rich fraction from the extract of licorice has been used as a gastrointestinal disorder and an anti-ulcer medicine (Fukai et al., 2002) , the mechanism is still elusive.
Since Black et al. first defined the H 2 R and its involvement in gastric acid secretion, H 2 R antagonists, for example, cimetidine, ranitidine, famotidine have been developed and used clinically as anti-acid secretagogues (Black et al., 1972) . These histamine H 2 R antagonists have revolutionized the treatment of peptic ulcers with their prominent therapeutic effects. Shibata reviewed that the components of G. uralensis have strong potency of anti-peptic ulcer effect (Shibata, 2000) . Constituents of G. uralensis include glycyrrhizic acid, glycyrrhetic acid , isoliquiritigenin (Shibata, 2000) . Since Fukai reported that flavonoid-rich fraction of licorice extract showed anti-ulcer effect (Fukai et al., 2002) , among the major constituents of licorice, we selected the isoliquiritigenin (4,2',4'-trihydroxychalcone), which has basic chemical structure of a flavonid, as a novel H 2 R antagonist and examined its effect on H 2 R activity.
Isoliquiritigenin has been reported as a potent antioxidant, cancer-preventing properties, and anti-platelet aggregation (Baba et al., 2002) . Isoliquiritigenin also reduce nitric oxide and suppress aberrant crypt foci development (Takahashi et al., 2004) . In present study, we used U937 and HL-60 hematopoietic cell lines and rat pylori-ligated model (Shay et al., 1954) , to evaluate the potential activity of isoliquiritigenin as H 2 R antagonist and anti-peptic ulcer agent against gastric ulcer. Through this study, we provide evidences that isoliquiritigenin negatively regulates most of the H 2 R's activity and clearly acts as a specific, competitive H 2 R antagonist in terms of blocking secretion of gastric acid and ulcer formation similar to the action of ranitidine. 
Materials and Methods

Materials
Three-dimensional model building
All the simulations were performed on Linux workstations using InsightII 2005 software package (Accelrys, CA, USA). The primary sequence of the human H 2 R (Swiss-Prot ID P25021) was used. Modeler program (Fiser et al., 2000) , which is an implementation of an 
Ligand preparation
Histamine and Isoliquiritigenin were sketched with the help of Builder module in InsightII 2005. Then the charges & potentials were assigned using CHARMM forcefield and the minimization was done using the CHARMM module in InsightII 2005 with 1000 steps of steepest descents followed by 10000 steps of conjugate gradients. To the minimized conformers, potentials and charges were once again assigned using CVFF forcefield and were saved in Sybylmol2 format.
Molecular Docking
The program GOLD (Genetic Optimisation for Ligand Docking, Cambridge
Crystallographic Data Centre, UK) was employed to dock the histamine and isoliquiritigenin 
Gastric secretion in Pylorus-Ligated Rat.
The pylorus-ligated rat model first described by Shay et al. (Shay et al., 1954) was used with some modification. Male Sprague-Dawley(SD) rats weighing 200-250g were used. Rats were deprived of food, but not water, for 18-24h prior to each experiment. The test substances (vehicle, ranitidine, isoliquiritigenin) dissolved in saline were administered orally (per os). After 1hr, rats were anesthetized by light ether, a small abdominal incision was made, the pylorus was ligated then indomethacine (40mg/kg) was injected through the duodenum. The animals were sacrificed 8hr after ligation of the pylorus, the stomach was clamped at the oesophageal and duodenal junctions, filled with 15ml of 4% formalin, and then rapidly removed. After 24hr, the fixed stomach was opened along the greater curvature, gently rinsed in saline, and then pinned open to expose the gastric mucosa. The haemorrhagic and ulcerative lesions were counted and measured with a light microscope by an observer who was blinded to the treatment. The ulcer index was then calculated as the sum of the diameter of all lesions. The ulcer index was determined in six animals in each animal group.
Histological examination.
The histological study of the stomach was performed following evaluation of the ulcer index.
Samples of the corpus were excised and transferred to fresh formalin and later processed by routine techniques prior to embedding in paraffin. Sections (5µm thick) were mounted on glass slides and stained with haematoxylin and eosin (HE). Coded slides were examined by an experienced pathologist blinded to the treatment.
Satistical analysis
All Quantitative data are expressed as mean ±S.E.M. Comparisons between two groups 1 1
were performed using Student's unpaired t-test. Differences were considered to be significant when the degree of confidence in the significance was 95% of better (P < 0.05).
Results
cAMP production by H 2 R agonist in U937 and HL-60 cells.
Histamine and dimaprit are known as highly selective histamine H 2 R agonists (Bakker et al., 2002) . U937 and HL-60 cells express H 2 R ( Fig. 2A, inset) , which is coupled to Gs-protein and mediates cAMP pathway (Shayo et al., 1997) . As shown in figure 2A , histamine and dimaprit induced cAMP increase in a concentration-dependent manner and half-maximal effective concentrations (EC 50 ) are 1.2 ± 1.3µM and 4.7 ± 0.2 µM, respectively.
Effect of isoliquiritigenin on H 2 R-mediated cAMP production.
We preliminarily investigated the inhibitory effect of licorice constituents (10µM each) on histamine and dimaprit (10µM each)-induced cAMP production in U937 cell line (data not shown). Among the components, isoliquiritigenin (Fig. 1B) exhibited the strongest inhibitiory effect. Fig. 2B represents that isoliquiritigenin inhibited histamine and dimaprit-induced cAMP production in a concentration-dependent manner similar with ranitidine (IC 50 values of ranitidine = 1.0 ± 0.7µM and ILG = 2.3 ± 0.1µM , respectively), suggesting that isoliquiritigenin inhibits H 2 R-mediated signals with similar effect of ranitidine.
Lack of direct effects of isoliquiritigenin on Gs-protein, adenylyl cyclase-and β 2 -adrenoceptor-mediated signaling.
As we mentioned above, H 2 R-mediated signaling posseses Gs-protein / adenylyl cyclase pathway (Klinker et al., 1996) . To clarify whether the isoliquiritigenin only effects on the H 2 R, we treated the cells with forsoklin, which directly activates adenylyl cyclase, isoproterenol, which activates Gs-protein coupled β 2 -adrenoceptor, and cholera toxin, which evokes Gsprotein activity. Fig. 3 shows that the addition of forskolin, isoproterenol, and cholera toxin (Fig. 4) , indicating that isoliquiritigenin selectively and competitively inhibited histamine binding to the H 2 R. were assigned using the CVFF forcefield and the receptor model was saved in sybylmol2 format.
Binding site analysis and docking
Then docking was performed with histamine and isoliquiritigenin. A goldscore of 39.08 and 48.91 was observed for the histamine and isoliquiritigenin, respectively. The docked poses of both the ligands in the human H 2 R model can be seen in Fig 5A & 5B, respectively. From our docking results, we demonstrated that histamine can form three hydrogen bonds with the receptor, which involve those from ethylamino group of histamine to side chain carboxyl group of Asp 98, from ethylamino group of histamine to main chain carbonyl group of Lys 166, and from N1 proton of histamine to main chain carbonyl group of Leu 274, respectively (Fig. 6A) , whereas isoliquiritigenin can also forms three hydrogen bonds with the receptor, which involve those from 4-OH-benzoyl group of isoliquiritigenin to main chain carbonyl of Leu 274, from 2-OH-benzoyl group of isoliquiritigenin to main chain carbonyl of Lys 166, and from carbonyl group of isoliquiritigenin to main chain amino group of Asn 168.
Effect of isoliquiritigenin on H 2 R in MKN-45 gastric cancer cell line.
MKN-45 gastric cancer cells express which mediate H 2 R cAMP signaling and increase H 2 R expression upon retinoic acid treatment (Nakata et al., 1996) . We treated MKN-45 with 5µM of retinoic acid for 72hr and tested the effect of isoliquiritigenin on dimaprit-induced cAMP generation. Similar to U937 cells, isoliquiritigenin also prominently inhibited dimapritinduced cAMP production in MKN-45 gastric cancer cells. Isoliquiritigenin, however, did not affect forskolin-induced adenylyl cyclase activation (Fig. 7) . These data indicate that isoliquiritigenin has inhibitory effect on H 2 Rs expressed not only in immune cell systems but also in gastric cells. For this reason, we extended our investigation whether isoliquiritigenin can reduce the gastic-ulceration in the stomach.
Effect of isoliquiritigenin on gastric acid secretion and gastric mucosal lesion formation.
There are many reports about the inhibitory effect of H 2 R antagonists on gastric acid secretion in animal model systems (Lamers, 1999) . H 2 R antagonists reduced volume of gastric acid production in pylori-ligated animal stomach and also significantly protected gastric mucosal lesion formation. In line with the above, we tested the effect of isoliquiritigenin on gastric acid-induced ulcer formation. In our experiment, isoliquiritigenin significantly prevented the gastric acid secretion (Fig. 8A ) and gastric-ulcer formation (Fig. 8B, Fig. 8C , and Fig. 8D) similar to the ranitidine effect. Our results demonstrate that isoliquiritigenin effectively inhibits gastric acid secretion and protects gastric mucosal layer similar to other H 2 R antagonists.
1 6
Discussion
Antagonism of histamine's action at H 2 R has been the corner stone of an immense market for pharmacological treatment of acid-peptic disorders of the gastrointestinal tract.
Through this study, we provided evidences that isoliquiritigenin directly inhibits the H 2 R activity and acts as an anti-peptic ulcer drug. First, we confirmed the existence of H 2 R in U937
and HL-60 cells through RT-PCR analylsis and isoliquiritigenin significantly blocked H 2 Rmediated cAMP production. In addition, MKN-45 gastric cells, isoliquiritigenin also inhibited H 2 R-mediated signaling, indicating that isoliquiritigenin does not depend on the cell type species. Second, isoliquiritigenin inhibits dimaprit-induced cAMP production via bloking of histamine binding to H 2 R, rather than accleration of degradation, since the inhibition was observed in the presence of the phosphodiesterase inhibitor, Ro20-1724. Third, isoliquiritigenin did not affect the activity of other histamine subtype receptors (H 1 R or H 3 R), cholera toxin, adenylyl cyclase-or β 2 adrenoceptor-mediated signaling pathway, suggesting that isoliquiritigenin is highly H 2 R-selective. Fourth, isoliquiritigenin reduced [ pylori-ligated rat model (Fig 8) . Previous reports demonstrated that drugs that are unable to inhibit acid secretion cannot suppress the lesion formation in this model, because these lesions are related mainly to the significant increase in acidity of gastric juice and this correlates well with the severity of erosions (Shibata et al., 1998) , showing that isoliquiritigenin can be very useful for peptic ulcer treatment.
Even though both histamine and isoliquiritigenin have three hydrogen bondings to the human histamine H 2 R model, the higher goldscore for the latter arises from the more favorable hydrophobic interactions within the receptor. Also the isoliquiritigenin does not appear to have a hydrogen bond with Asp 98 which is crucial for histamine binding. From our studies we can speculate that isoliquiritigenin has more favorable interactions with histamine H 2 R due to more hydrophobic interaction compared to histamine. Also suitable substitutions on the isoliquiritigenin that facilitates hydrogen bonding with side chain carboxyl group of Asp 98 may 1 8
contribute to isoliquiritigenin's antagonistic activity on the human H 2 R.
As shown in Fig.1 , most H 2 R antagonists (ranitidine (Fig. 1D) , cimetidine (Fig. 1E) , and famotidine (Fig. 1F) ) are optimized through histamine-structure lead (Fig. 1C) . Isoliquilitigenin, however, neither have any structural similarity with these compounds nor have histamine moiety, suggesting that isoliquilitigenin can be used as novel H 2 R antagonist. Mild diarrhoea, neuropsychiatric disorders, gynecomastia, impotence, dizziness, rashes, confusion, headaches and reversible liver damage have been reported by some people using histamine-derived H 2 R
antagonists as an anti-ulcer treatment (Zimmerman, 1984) . Since isoliquiritigenin is purified from natural product, licorice (Ma et al., 2005) , it may be considered as safe anti-ulcer treatment.
In previous reports, activation of H 2 R can lead cell proliferation and also activate transcription of the gene encoding c-fos in a protein kinase C (PKC)-dependent manner (Wang et al., 1997) . Cell proliferation often requires a series of signaling steps that act in a coordinated manner to regulate nuclear events responsible for controlling cell division. Previous reports proved that H 2 R regulates c-Fos and c-Jun mRNA and protein level in numerous system (Shayo et al., 1997) . Like as previous reports, dimaprit transiently elevated c-Fos levels (supplement data). In addition, we observed that the levels of c-Jun protein treated with H 2 agonist showed similar pattern (supplement data). However, in the presence of 10µM of isoliquiritigenin, dimaprit-induced elevation of c-Fos and c-Jun protein level were completely inhibited (supplement data). These data demonstrate here that isoliquiritigenin negatively regulates H 2 R mediated c-Fos / c-Jun protein expression.
In conclusion, our results show that isoliquiritigenin is a novel, specific, and competitive histamine H 2 R antagonist with antisecretory and antiulcer effects similar potent with those of ranitidine. It also induces gastroprotective effects and might provide the basis for designing novel H 2 R antagonists. 
